Both in Pharmaceuticals
Design Therapeutics vs Immix Biopharma
Over the past year DSGN returned +55.0% and IMMX returned +99.5%; their daily moves had a correlation of 0.32.
DSGN +55.0% IMMX +99.5%Growth of $1, one year, split-adjusted
| Metric | DSGN | IMMX |
|---|---|---|
| Price | $10.15 | $7.26 |
| Market cap | $635.2M | $601.9M |
| Today | −4.96% | −5.47% |
| 1 month | −17.7% | −25.0% |
| 6 months | −22.9% | −23.4% |
| Year to date | +8.2% | +38.8% |
| 1 year | +55.4% | +97.8% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $207.4M | $232.1M |
| Dividend yield | — | — |
| Volatility (60d) | 55.4% | 68.7% |
| Short % of float | 21.8% | 22.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).